Urine Albumin Test (ACR): Microalbuminuria Explained
The urine albumin test (ACR) finds albumin in urine, an early sign of kidney disease. Learn normal uACR levels in mg/g and what microalbuminuria means.
The urine albumin test measures albumin — a blood protein — in your urine, not in your blood. Healthy kidneys keep almost all albumin out of the urine, so finding it there is one of the earliest and most useful signs of kidney damage, often appearing before your blood creatinine or eGFR budges. It is usually reported as the urine albumin-to-creatinine ratio (uACR or ACR) from a single spot urine sample. This guide explains what the ACR test measures, normal uACR levels in mg/g, what microalbuminuria means, why it is a key early marker of diabetic and hypertensive kidney disease and cardiovascular risk, and when a high result should be repeated. It is a core part of a kidney function work-up.
Don't confuse the two. The urine albumin test measures albumin in your urine (albuminuria) and tracks your kidneys. It is not the same as a blood albumin test, which measures albumin in the blood and reflects nutrition and liver function. This guide is about the urine test.
Key takeaways
- The urine albumin test detects albumin leaking into the urine — a leak the kidneys normally prevent — making it an early marker of kidney damage and a predictor of kidney and cardiovascular outcomes.12
- It is reported as the urine albumin-to-creatinine ratio (uACR) on a spot urine sample, ideally a first-morning void. This has replaced the old 24-hour urine collection.34
- Normal is a uACR below 30 mg/g (category A1). 30–300 mg/g is category A2 — the old "microalbuminuria." Above 300 mg/g is category A3 (severely increased albuminuria).34
- A single high result can be transient (fever, hard exercise, a urinary tract infection, dehydration). A true elevation is confirmed by repeating the test, ideally two of three samples over 3–6 months.15
- In people with diabetes or high blood pressure, the ACR is checked at least once a year because it flags early kidney disease while it is still treatable.67
- Combined with your eGFR, the uACR is how clinicians stage chronic kidney disease and estimate risk; lowering albuminuria with modern therapy slows kidney disease.389
What is the urine albumin test (ACR)?
Albumin is the most abundant protein in your blood. In a healthy kidney, the filtering units — the glomeruli — hold albumin back, so only a trace reaches the urine. When those filters are damaged, albumin begins to leak into the urine. That leak, called albuminuria, is one of the first signs of kidney disease, frequently showing up before blood creatinine rises.15
Rather than collect 24 hours of urine (cumbersome and error-prone), labs now measure the urine albumin-to-creatinine ratio (uACR) — also written ACR or albumin-creatinine ratio — on a single spot sample. Dividing urine albumin (in mg) by urine creatinine (in g) corrects for how dilute or concentrated your urine is on that day, which makes one sample reliable.41 You may also see it called a microalbumin test or microalbumin creatinine ratio — different names for the same measurement.5 It is a standard part of the kidney function tests.
Why the test is done
Clinicians order a urine albumin test to:7103
- screen for early kidney damage, especially in people at risk — those with diabetes, high blood pressure, or a family history of kidney disease;
- monitor known chronic kidney disease (CKD), since the uACR helps grade its severity and risk of progression;
- estimate cardiovascular risk — albuminuria predicts not only kidney failure but also heart attacks, strokes, and death, even at moderate levels;2
- watch for kidney involvement in pregnancy, where new protein in the urine plus high blood pressure raises concern for preeclampsia.11
For people with diabetes, U.S. guidelines are specific: the American Diabetes Association recommends screening the uACR (and eGFR) at least once a year — starting at diagnosis in type 2 diabetes and after five years in type 1.6 The CDC likewise counts the urine albumin test as one of the two core tests for CKD, alongside eGFR.7 This matters because early kidney disease is silent: the test finds it while there is still time to act.
How the test is done
The test uses a simple urine sample — no needle, no fasting. You urinate into a collection cup, and the lab measures albumin and creatinine to compute the ratio.5
- A first-morning sample is preferred. The first void of the day gives the most reproducible result and limits the effect of daytime activity.34
- A random ("spot") sample collected any time of day is also acceptable and is what many clinics use.5
- You do not need to fast. Fasting is a blood-test rule; it does not apply to a urine albumin test.
Try to avoid testing right after vigorous exercise, during a urinary tract infection, during your period, or while you have a fever — all of these can push albumin up temporarily.15 If any blood tests in your kidney work-up require fasting, follow your provider's instructions; the urine albumin portion does not.
Normal ranges: the uACR categories
Below is the reference classification (KDIGO, echoed by the National Kidney Foundation) for the urine albumin-to-creatinine ratio. The thresholds are the same whether your report uses mg/g, mg/mmol, or mg/24 h — read the units on your report.34
| Category | uACR (mg/g) | uACR (mg/mmol) | Interpretation |
|---|---|---|---|
| A1 | < 30 | < 3 | Normal to mildly increased |
| A2 | 30 – 300 | 3 – 30 | Moderately increased ("microalbuminuria") |
| A3 | > 300 | > 30 | Severely increased ("macroalbuminuria") |
Micro or macro? "Microalbuminuria" (A2) is the older name for a moderate albumin leak — often the first sign of kidney damage, especially in diabetes. "Macroalbuminuria" (A3) is a heavier leak, close to what used to be called overt proteinuria. Current guidelines favor the neutral labels A1/A2/A3 and the plain terms moderately and severely increased.3 A single number above the cutoff is not a diagnosis — only your clinician interprets it in context.
Note the key point the National Kidney Foundation stresses: a uACR above 30 mg/g may signal kidney disease even when your eGFR is above 60 — which is why the two tests are always read together.4
What high albuminuria means
A high uACR means the glomerular filters are letting too much albumin through. Before concluding anything, the result is confirmed on repeat testing, because many everyday things raise it briefly (see the next section). Guidelines define persistent albuminuria as elevation in at least two of three samples over 3–6 months.31
Once confirmed, elevated albuminuria most often points to chronic kidney disease, and the two leading causes in the U.S. are diabetes and high blood pressure.710
Diabetic and hypertensive kidney disease. In diabetes, a rising uACR — moving from A1 into A2 — is frequently the earliest measurable sign of diabetic kidney disease, at a stage when treatment can slow or even stabilize it. The same is true for kidney damage from long-standing high blood pressure. This is exactly why annual screening exists: to catch the leak early.63 Alongside albuminuria, your clinician reads your creatinine and eGFR, your blood pressure, and — in diabetes — your A1C.
Cardiovascular risk. A point that is easy to miss: albuminuria is not only about the kidneys. A large international analysis found that higher albuminuria is associated with more kidney failure, but also more cardiovascular events and higher overall mortality — and this holds even at the moderate (A2) level, and even when eGFR is normal.2 The urine albumin test is, in effect, a window on the health of your blood vessels as a whole.
Staging. The uACR does not stand alone. Combined with eGFR, it places you in the KDIGO CGA framework (Cause, GFR category G1–G5, and Albuminuria category A1–A3) that grades how advanced CKD is and how likely it is to progress — the map that guides monitoring and treatment.3
Causes of a transient high result
Many temporary factors can raise a uACR without meaning your kidneys are damaged, which is why a high value is repeated before any conclusion:15
- a fever or an infection, especially a urinary tract infection;
- vigorous physical exercise in the hours before the test;
- dehydration, a spike in blood pressure, or very high blood sugar;
- menstrual blood contaminating the sample, or a poorly collected specimen;
- heart failure and, in pregnancy, normal physiologic changes.
Because of all this, a single elevated result is best re-checked, ideally on a first-morning sample and away from illness or hard exercise. If two of three tests over several weeks stay high, the albuminuria is considered persistent and is worked up as kidney disease.3
When to see a doctor
Albuminuria itself causes no symptoms — you cannot feel it, which is the whole reason it is screened for. Talk with your clinician if:
- you have diabetes or high blood pressure and have not had a uACR in the past year;67
- a routine urine albumin test comes back at or above 30 mg/g, so it can be confirmed and interpreted alongside your eGFR;4
- you notice persistently foamy or frothy urine, swelling in your legs or around your eyes, which can accompany a heavier protein leak;
- you are pregnant and are told there is protein in your urine, particularly with rising blood pressure — a combination that needs prompt evaluation for preeclampsia.11
The goal is not to panic over one number but to act early: at the microalbuminuria stage, well-chosen treatment can meaningfully slow kidney disease.
Recent research
According to recent PubMed publications:
- Albuminuria as a central marker — and a treatment target. A 2025 practical review confirms that albuminuria testing is a key biomarker for the detection, prognosis, and surveillance of both kidney and cardiovascular disease, now built into treatment strategies.1
- SGLT2 inhibitors protect the kidneys across all albuminuria levels. A 2026 meta-analysis of large trials found these drugs slow CKD progression regardless of baseline albuminuria — reinforcing the value of measuring it. Landmark trials such as DAPA-CKD enrolled patients based on their albuminuria.8
- Finerenone lowers albuminuria and complications. In type 2 diabetes with CKD, this therapy reduced kidney and cardiovascular events; the analysis underscored using the urine albumin test to identify high-risk patients who benefit most.9
- A confirmed global risk marker. The link between higher albuminuria and kidney, cardiovascular, and mortality risk has been established at very large scale, even for moderately increased (A2) levels.2
These findings concern medical management; they do not justify self-treatment, and any therapy is decided by your physician.
Get your urine albumin result interpreted by AI DiagMe
A uACR is never read alone: its meaning depends on your creatinine and eGFR, your blood pressure, your blood sugar and A1C, your context (diabetes, pregnancy), and whether the result is confirmed — a single value can be transient.
👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.
Frequently asked questions
What is the ACR (albumin-creatinine ratio) test and what is a normal level?
Is the urine albumin test a blood test?
What does microalbuminuria mean, and is it serious?
Why do people with diabetes need this test every year?
Do I need to fast, and which sample is best?
Albuminuria in pregnancy — should I worry?
Bottom line
The urine albumin test finds albumin leaking into the urine — a leak healthy kidneys prevent — making it an early sign of kidney damage and a predictor of kidney and cardiovascular risk. It is reported as the uACR on a spot (ideally first-morning) sample: normal below 30 mg/g; 30–300 mg/g is microalbuminuria (A2); above 300 mg/g is severely increased (A3). A high value is confirmed on repeat testing, since many causes are transient. Once confirmed, it points most often to diabetes or high blood pressure — and catching it early is genuinely good news, because it can then be slowed. No value is read in isolation: what matters is the full picture — your uACR read with your eGFR, blood pressure, and A1C, within your kidney work-up — which is what AI DiagMe provides, alongside your physician.
Sources
Official sources and peer-reviewed publications (PubMed) used for this guide:
Footnotes
-
Beernink JM, van Mil D, Laverman GD, Heerspink HJL, Gansevoort RT. Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease — A practical update for clinicians. Diabetes Obes Metab, 2025. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
Grams ME, Coresh J, Matsushita K, et al. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA, 2023. PubMed · DOI ↩ ↩2 ↩3 ↩4
-
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int, 2024. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13
-
National Kidney Foundation — Urine Albumin-Creatinine Ratio (uACR). kidney.org ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Microalbumin Creatinine Ratio. medlineplus.gov ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025. Diabetes Care, 2025. diabetesjournals.org · PubMed ↩ ↩2 ↩3 ↩4 ↩5
-
Centers for Disease Control and Prevention (CDC) — Testing for Chronic Kidney Disease. cdc.gov ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Neuen BL, Fletcher RA, Heerspink HJL, et al. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis. JAMA, 2026. PubMed · DOI ↩ ↩2
-
Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J, 2022. PubMed · DOI ↩ ↩2
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) — Chronic Kidney Disease (CKD): Tests & Diagnosis. niddk.nih.gov ↩ ↩2
-
Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol, 2022. PubMed · DOI ↩ ↩2 ↩3